Jpmorgan Chase & CO Bio Path Holdings Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.36 - $1.78 $153 - $756
-425 Reduced 98.15%
8 $0
Q2 2023

Aug 11, 2023
SELL
$1.22 - $2.13 $25 - $44
-21 Reduced 4.63%
433 $0
Q1 2023

May 11, 2023
BUY
$1.39 - $2.26 $631 - $1,026
454 New
454 $0

About BIO-PATH HOLDINGS INC

BPTH Quotes by TradingView
  • Ticker BPTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,160,160
  • Market Cap $5.51M
  • Description
  • Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...
More about BPTH
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email